Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study by Xu, L et al.
Title
Effect of alcohol and aldehyde dehydrogenase gene
polymorphisms on alcohol-associated hypertension: the
Guangzhou Biobank Cohort Study
Author(s) Sen Zhang, W; Xu, L; Schooling, CM; Jiang, CQ; Keung Cheng,K; Liu, B; Lam, TH
Citation Hypertension Research, 2013, v. 36 n. 8, p. 741-746
Issued Date 2013
URL http://hdl.handle.net/10722/184815
Rights Creative Commons: Attribution 3.0 Hong Kong License
OPEN
ORIGINAL ARTICLE
Effect of alcohol and aldehyde dehydrogenase gene
polymorphisms on alcohol-associated hypertension:
the Guangzhou Biobank Cohort Study
Wei Sen Zhang1,4, Lin Xu2,4, Catherine Mary Schooling2, Chao Qiang Jiang1, Kar Keung Cheng3, Bin Liu1
and Tai Hing Lam2
The effects of alcohol dehydrogenase (ADH) 2 and aldehyde dehydrogenase (ALDH) 2 genotypes on the alcohol–blood pressure
association are unclear. We examined the association of ADH2 or ALDH2 genotypes with blood pressure in older Chinese men.
Based on the Guangzhou Biobank Cohort Study (GBCS), 4792 men with valid ADH2, ALDH2 genotypes were included, and
genotyping of rs1229984 ADH2 and rs671 ALDH2 (AA, AG/GA or GG) was performed using a Sequenom Mass-Array platform.
Information on socio-demographics and lifestyle factors, including alcohol use, was obtained from a questionnaire, and blood
pressure was measured. Among alcohol drinkers, systolic and diastolic blood pressure (SBP and DBP) and mean arterial
pressure (MAP) were highest for men with the GG ADH2 genotype (136.6, 77.9 and 97.5 mm Hg, respectively), followed by
those with the (AA/AG ADH2þGG ALDH2) genotype (133.4, 77.6 and 96.2 mm Hg, respectively) and then the (AA/AG
ADH2þAA/AG ALDH2) genotype (SBP¼132.6, DBP¼76.6 and MAP¼95.2 mm Hg) (P for trend ranged 0.025–0.035).
After adjustment for potential confounders, as well as frequency or amount of alcohol use, men with the GG ADH2 genotype
were more likely to have hypertension (odds ratio (OR)¼1.62, 95% confidence interval 1.15–2.28) as were men with the
(AA/AG ADH2þAA/AG ALDH2) genotype (OR¼1.40, 95% confidence interval 1.01–1.96) compared with men with the
(AA/AG ADH2þGG ALDH2) genotype). ADH2 or ALDH2 genotypes were unrelated to hypertension among those who never
drink alcohol. ADH2 genotype influences blood pressure and risk of hypertension among male alcohol drinkers, suggesting
that the hypertensive effect of alcohol is due to ethanol rather than acetaldehyde.
Hypertension Research (2013) 36, 741–746; doi:10.1038/hr.2013.23; published online 25 April 2013
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INTRODUCTION
Alcohol consumption is increasingly popular in China.1 Based on a
WHO report, alcohol consumption per capita in pure ethanol for
Chinese adults was 1.03 litres in 1970, and rose to 4.5–5.2 litres in
1996–2001.2–4 The increasing use of alcohol has caused a great health,
financial and social burden in China, yet alcohol consumption is
continuing to rise. Local research is urgently needed to provide
supporting evidence for developing a policy for alcohol restriction to
improve public health.
Alcohol has been linked to hypertension in previous studies, and
the association was partly explained by genetic variation in alcohol
metabolism.5 Studies in Japanese and other East Asian populations
have compared the alcohol–blood pressure relationships among
individuals with varying activities of alcohol-metabolizing enzymes,
such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase
(ALDH),6,7 and have shown important roles for these enzymes in the
metabolism of alcohol in the body.8 After alcohol intake, ethanol is
firstly metabolized to acetaldehyde then to acetic acid through several
mechanisms. The main enzymes involved in the metabolic process are
ADH2 and ALDH2 enzymes.9–11 The activities of these enzymes differ
with genetic polymorphisms, leading to different effects of alcohol
consumption on health. The GG and AA ALDH2 genotypes encode
the active and the inactive subunit, respectively.12,13 The AA ALDH2
genotype results in higher blood acetaldehyde levels after alcohol
intake, leading to facial flushing, palpitations and nausea.7,14 A meta-
analysis of studies using ALDH2 single-nucleotide polymorphisms as
an instrumental variable for alcohol use showed that alcohol
significantly increased blood pressure and risk of hypertension in
individuals of AA genotype.5 However, this meta-analysis was
designed to assess the effect of alcohol use, and specifically ethanol,
on blood pressure, but the effect of the ADH2 genotype on blood
pressure was not assessed. As the isozymes of ADH2 encoded by the
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AA and AG genotypes have about 200 and 100 times higher ethanol
oxidizing capacity, respectively, than the GG ADH2 genotype,15 the
effect of alcohol on blood pressure should vary with ADH2 genotype.
A previous study on men found that subjects with the GG genotype
of ADH2 had higher blood pressure than those with the GA or AA
genotype,16 but this study did not consider whether the association
varied with ALDH2 genotype, despite the effects of ALDH2 on
alcohol metabolism. Figure 1 shows the likely exposures for different
combinations of ADH2 and ALDH2 genotypes. Individuals with an
inactive ADH2 (GG) genotype metabolize alcohol slowly and have
high ethanol exposure on alcohol use. Individuals with an inactive
ALDH2 (AA or AG) genotype metabolize acetaldehyde slowly and
have high acetaldehyde exposure on alcohol use. Individuals with an
active ADH2 (AA or AG) genotype and an active ALDH2 (GG)
genotype metabolize both ethanol and acetaldehyde quickly and have
high acetic acid exposure on alcohol use. We hypothesized that in
alcohol drinkers, those with an inactive ADH2 (GG) genotype have
higher levels of ethanol than those with an active genotype and that
this genotype may be associated with a higher risk of hypertension
after alcohol drinking.
In the GBCS, we examined the associations of ADH2 and ALDH2
genotypes with blood pressure in men, and whether the associations
varied with drinking status (alcohol drinker or never drinker).
METHODS
Ethics statement
All subjects had given informed consent before participating. The study has
ethics approval from the Guangzhou Medical Ethics Committee of the Chinese
Medical Association, Guangzhou, China.
The details of the GBCS
The GBCS is a 3-way collaboration among the Guangzhou No. 12 Hospital,
the Universities of Hong Kong and Birmingham. The details have been
reported elsewhere.17 Briefly, participants were recruited from the ‘Guangzhou
Health and Happiness Association for the Respectable Elders’, a community
social and welfare association unofficially aligned with the municipal
government. This is a large unofficial organization with more than 150
branches throughout Guangzhou. The membership is open to Guangzhou
residents aged 50 years or above for a nominal fee of 4 CNY (50 US cents) per
month. Members of the Guangzhou Health and Happiness Association for the
Respectable Elders account for about 7% of older permanent residents in
Guangzhou. Approximately one-third of them participated in the GBCS if they
were capable of consenting, ambulatory and not receiving treatment modalities
that, if omitted, may result in immediate life-threatening risk, such as
chemotherapy or radiotherapy for cancer, or dialysis for renal failure. As
participants in the GBCS could receive a free medical examination, the
response rate was very high (about 95%). About 5% of the eligible subjects
refused to participate, particularly men, because of a cultural unwillingness to
give blood due to an associated loss of ‘shung qi’ or ‘life energy’, or because of
job commitments. The baseline examinations were conducted in three phases:
phase 1 from September 2003 to November 2004, phase 2 from April 2005 to
May 2006 and phase 3 from September 2006 to January 2008. The second
examination started in 2008 and in progress.
Computer based face-to-face interview and detailed physical examinations
were done at baseline recruitment. Information on alcohol consumption was
obtained in terms of frequency and usual amount per occasion for specific
types of alcoholic beverage. Seated blood pressure was measured three times
using an automated sphygmomanometer (Omron 705CP; Omron Corp.,
Kyoto, Japan), which had been previously validated by comparison with the
manual mercury sphygmomanometer,18 and the last two measurements were
averaged for analysis.
Blood samples were collected following 8–10 h overnight fasting. Blood
samples for DNA extraction were available in phase 3 at baseline and in phases
1 and 2 at follow-up. DNA exaction was performed at the laboratory center of
the GBCS in Guangzhou 12th Hospital.19 DNA was either extracted at baseline
from fresh blood using a standard phenol–chloroform extraction procedure or
was extracted from blood or buffy coat previously stored at 80 1C using a
standard magnetic bead extraction procedure. single-nucleotide polymorphism
analysis was performed using a Sequenom Mass-Array platform, which
amplifies DNA with specific primers, deactivates remaining nucleotide tripho-
sphates by phosphatase treatment, performs a single base primer extension step
and identifies allele-specific extension products using mass spectroscopy.
Outcomes
After resting for 5 min, seated SBP and DBP was measured three times using
an automated sphygmomanometer (Omron 705CP), which had been pre-
viously validated by comparison with the manual mercury sphygmoman-
ometer,18 and at least 1 min rest interval was required between each
measurement. The last two measurements were averaged for data analysis in
the present study. Outcomes considered were SBP, DBP, pulse pressure, defined
as SBPDBP, MAP defined as 1/3 (SBPþDBP 2) and hypertension
defined as use of antihypertensive medication or SBP/DBP X140/90 mm Hg.
Exposures
Exposures considered were rs671 ALDH2 genotype, rs1229984 ADH2 geno-
type and their combination, as set out in Figure 1, which shows how ADH2
and ALDH2 were combined to represent ethanol, acetaldehyde or acetic acid
exposure.
Statistical analysis
We used genetic polymorphism of alcohol metabolism enzyme (ALDH2 and
ADH2 genotypes) as the instrumental variable to obtain an unbiased
estimation of the effect of alcohol on blood pressure. As genetic differences
are determined before birth, these are unlikely to be associated with exogenous
exposures or environmental factors. Thus the estimation might not be
confounded by common hypertensive risk factors, such as smoking or sodium
intake, as in other observational studies. Multivariable linear regression was
used to assess differences in continuous variables between genotypes with
adjustment for potential confounders, giving adjusted means and 95%
confidence intervals, as well as P-value for trend. Logistic regression was used
to assess the association of ADH2 and ALDH2 polymorphism with hyperten-
sion with adjustment for potential confounders. We assessed whether the
association of ADH2 with the outcomes varied with ALDH2 from the P-value
for interaction. We similarly assessed whether the association of ADH2,
ALDH2 or the combined ADH2/ALDH2 genotype with the outcomes varied
with drinking status. Potential confounders were age, occupation (manual,
nonmanual, others), education, International Physical Activity Questionnaire
physical activity (active, moderate, and inactive),20 smoking (never, former and
current), body mass index, fasting plasma glucose and total and high-density
lipoprotein cholesterol. We excluded former drinkers when assessing the
association of ADH2 and ALDH2 genotypes with blood pressure to reduce
the ‘abstainer error’, as former drinkers might have quitted drinking because of
ill-health including hypertension, and received antihypertensive medication.21
Statistical significance was defined as a two-sided P-valueo0.05. Data analysis
was performed using STATA 10.1 (Stata Corp LP, College Station, TX, USA).
Figure 1 Effect of ADH2 and ALDH2 genotype on alcohol metabolism in
human.
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There were 4792 men with valid ADH2 and ALDH2 genotypes and
complete information about all potential confounders. The AA, AG
and GG genotype frequencies of ADH2 and ALDH2 were 52.7%,
40.2% and 7.1%, and 8.6%, 41.6% and 49.8%, respectively. The
Hardy–Weinberg equilibrium test showed no variance between the
population under study and the general population (P¼ 0.77 for
ADH2 and 0.99 for ALDH2 genotypes).
Table 1 shows that the ADH2 genotype was unrelated to drinking
status or frequency, or to other risk factors, such as smoking, physical
activity, education, occupation, age, body mass index, total and high-
density lipoprotein-cholesterol, triglycerides and fasting glucose.
Current drinking and higher alcohol use (X140 g per week) were
more common among men with the GG ADH2 genotype (P¼ 0.050
and 0.026, respectively) than men with the other ADH2 genotypes.
Current drinking, frequent alcohol drinking (X5 per week)
and higher alcohol use (X140 g per week) were all more common
among men with the GG than the AA or AG ALDH2 genotypes
(all Po0.001). Men with the AA ALDH2 genotype were more likely
to have had manual occupations (P¼ 0.040) and lower total and
high-density lipoprotein-cholesterol (P¼ 0.036 and 0.005,
respectively).
There was no evidence that the association of ADH2 with the
outcomes varied with ALDH2, probably because of insufficient
sample size (P-values ranged from 0.19 to 0.44; table not shown).
Similarly, there was no evidence that the association of ADH2 or
ALDH2 with the outcomes varied with drinking status; however, the
association of the combined ADH2/ALDH2 group with some out-
comes did vary with drinking status (SBP P¼ 0.035, DBP P¼ 0.035
and MAP P¼ 0.025). Table 2 shows that in never drinkers, ADH2 and
ALDH2 were unrelated to SBP, DBP, pulse pressure or MAP. Among
current drinkers, compared with the AA or AG ADH2 genotype, men
with the GG genotype had higher SBP and pulse pressure (Po0.05).
ALDH2 genotypes were unrelated to SBP, DBP, pulse pressure
or MAP. After adjusting for multiple potential confounders and
frequency of drinking, SBP, DBP and MAP were highest for men with
the GG ADH2 genotype, followed by those with the (AA/AG
ADH2þGG ALDH2) genotype and then the (AA/AG ADH2þAA/
AG ALDH2) genotype (P for trend ranged 0.025–0.035) (Table 2).
Sensitivity analysis with additional adjustment for amount of alcohol
Table 1 Characteristics by ADH2 and ALDH2 genotypes in older Chinese men
ADH2 (rs1229984, n¼4792) ALDH2 (rs671, n¼4782)
AA AG GG P AA AG GG P
Cases, % 2524 (52.7) 1927 (40.2) 341 (7.1) 0.77a 409 (8.6) 1990 (41.6) 2383 (49.8) 0.99a
Drinking, n (%) Never 1350 (53.5) 955 (49.6) 162 (47.5) 0.050 315 (77.0) 1173 (58.9) 969 (40.7) o0.001
Former 139 (5.5) 122 (6.3) 20 (5.9) 9 (2.2) 100 (5.0) 172 (7.2)
Current 1035 (41.0) 850 (44.1) 159 (46.6) 85 (20.8) 717 (36.0) 1242 (52.1)
Frequency of drinking, n (%) Never 1350 (53.5) 955 (49.6) 162 (47.5) 0.26 315 (77.0) 1173 (58.9) 969 (40.7) o0.001
o1 per month 537 (21.3) 415 (21.5) 82 (24.0) 70 (17.1) 432 (21.7) 536 (22.5)
o1 per week 99 (3.9) 86 (4.5) 15 (4.4) 5 (1.2) 83 (4.2) 110 (4.6)
1–4 per week 142 (5.6) 120 (6.2) 18 (5.3) 4 (1.0) 78 (3.9) 196 (8.2)
X5 per week 257 (10.2) 229 (11.9) 44 (12.9) 6 (1.5) 124 (6.2) 400 (16.8)
Former drinkers 139 (5.5) 122 (6.3) 20 (5.9) 9 (2.2) 100 (5.0) 172 (7.2)
Amount of alcohol use, n (%) Never 1350 (53.5) 955 (49.6) 162 (47.5) 0.026 315 (77.0) 1173 (58.9) 969 (40.7) o0.001
o140 g per week 1005 (39.8) 852 (44.2) 154 (45.2) 91 (22.2) 767 (38.5) 1151 (48.3)
X140 g per week 169 (6.7) 120 (6.2) 25 (7.3) 3 (0.7) 50 (2.5) 263 (11.0)
Smoking, n (%) Never 1010 (40.0) 769 (39.9) 157 (46.0) 0.09 170 (41.6) 812 (40.8) 951 (39.9) 0.74
Ever 1514 (60.0) 1158 (60.1) 184 (54.0) 239 (58.4) 1178 (59.2) 1432 (60.1)
Physical activity, n (%) Inactive 216 (8.6) 126 (6.5) 33 (9.7) 0.09 39 (9.5) 160 (8.0) 178 (7.5) 0.13
Moderate 1006 (39.9) 785 (40.7) 131 (38.4) 152 (37.2) 767 (38.5) 994 (41.7)
Active 1302 (51.6) 1016 (52.7) 177 (51.9) 218 (53.3) 1063 (53.4) 1211 (50.8)
Education, n (%) Primary or below 724 (28.7) 546 (28.3) 102 (29.9) 1.00 109 (26.7) 589 (29.6) 674 (28.3) 0.29
Junior middle 769 (30.5) 587 (30.5) 106 (31.1) 121 (29.6) 600 (30.2) 734 (30.8)
Senior middle 621 (24.6) 482 (25.0) 81 (23.8) 112 (27.4) 505 (25.4) 567 (23.8)
College 410 (16.2) 312 (16.2) 52 (15.2) 67(16.4) 296(14.9) 408(17.1)
Occupation, n (%) Manual 1285 (50.9) 931(48.3) 188(55.1) 0.12 217(53.1) 1028(51.7) 1153(48.4) 0.040
Nonmanual 973 (38.5) 768(39.9) 120(35.2) 156(38.1) 731(36.7) 970(40.7)
Others 266 (10.5) 228 (11.8) 33 (9.7) 36 (8.8) 231 (11.6) 260 (10.9)
Age, year (s.d.) 63.6 (6.9) 63.5 (6.9) 63.6 (6.9) 0.95 63.4 (6.9) 63.6 (7.0) 63.5 (6.9) 0.66
Body mass index, kgm2 (s.d.) 23.5 (3.2) 23.5 (3.1) 23.7 (3.0) 0.56 23.5 (3.0) 23.5 (3.1) 23.5 (3.2) 0.95
Total cholesterol, mmol l1 (s.d.) 5.59 (1.06) 5.57 (1.08) 5.52 (0.92) 0.49 5.45 (0.99) 5.57 (1.07) 5.60 (1.07) 0.036
Triglycerides, mmol l1 (s.d.)b 1.43 (1.73) 1.40 (1.73) 1.40 (1.70) 0.35 1.42 (1.67) 1.40 (1.71) 1.43 (1.75) 0.35
HDL cholesterol, mmol l1 (s.d.) 1.52 (0.37) 1.51 (0.37) 1.50 (0.35) 0.82 1.47 (0.35) 1.50 (0.37) 1.53 (0.38) 0.005
Fasting glucose, mmol l1 (s.d.)b 5.59 (1.21) 5.59 (1.22) 5.57 (1.20) 0.92 5.57 (1.21) 5.58 (1.21) 5.60 (1.22) 0.68
Abbreviations: ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase.
aHardy–Weinberg equilibrium test.
bData was expressed as geometric means (s.d.).
Alcohol-associated hypertension
WS Zhang et al
743
Hypertension Research
use instead of frequency of drinking showed similar results
(Table not shown).
Table 3 shows that among ever drinkers, men with the GG ADH2
genotype had higher odds of hypertension than those with the (AA/
AG ADH2þAA/AG ALDH2) genotype after adjusting for frequency
of alcohol drinking and other risk factors (OR¼ 1.62, 95% confidence
interval 1.15–2.28). Sensitivity analysis found similar results after
adjusting for amount of alcohol drinking and other risk factors
(OR¼ 1.61 (1.14–2.27)). Compared with (AA/AG ADH2þ GG
ALDH2), the adjusted OR for GG ADH2 was 1.40 (1.01, 1.96).
Among men with the AA/AG ADH2 genotype, the ALDH2 genotype
was not significantly associated with hypertension. (Table not shown)
Among never drinkers, ADH2 or ALDH2 genotypes were not
associated with hypertension.
Sensitivity analysis with adjustment for interaction of ADH2/
ALDH2 genetic polymorphism with gender, age and antihypertensive
medication use also showed similar results. The interactions between
ADH2/ALDH2 genetic polymorphism and these potential effect
modifiers, such as gender, age and antihypertensive medication use
on blood pressure levels or hypertension, were all nonsignificant
(P-values from 0.21 to 0.94).
DISCUSSION
To the best of our knowledge, this is the first study in which the
association of ADH2 and ALDH2 genotypes with hypertension has
been investigated in a large community-based Chinese sample. ADH2
genotype but not ALDH2 genotype was a determinant of blood
pressure among alcohol drinkers; alcohol drinkers with the GG ADH2
genotype had higher blood pressure than alcohol drinkers with other
genotypes, after adjusting for frequency or amount of alcohol use,
suggesting that ethanol may have a key role in alcohol-induced
hypertension.
Our results support studies that showed a significant interaction
between ADH2 and alcohol drinking on blood pressure22 and no
relationship between ALDH2 and blood pressure.22–24 As ALDH2 has
been shown to be associated with blood pressure through affecting
Table 2 Association of ADH2 and ALDH2 genotypes with blood pressure in older Chinese men
Adjusted meansa (95% CI)
n Systolic BP Diastolic BP PP MAP
Never drinkers
ADH2(rs1229984) 2467
Group 1 AA 1350 132.6 (131.3, 133.9) 75.2 (74.5, 75.9) 57.4 (56.4, 58.3) 94.3 (93.5, 95.2)
Group 2 AG 955 133.0 (131.5, 134.5) 75.0 (74.2, 75.8) 57.9 (56.9, 59.0) 94.3 (93.4, 95.3)
Group 3 GG 162 131.4 (128.3, 134.5) 73.3 (71.7, 75.0) 58.0 (55.9, 60.2) 92.7 (90.7, 94.7)
P for trend 0.79 0.09 0.36 0.28
ALDH2 (rs671) 2457
Group 1 AA 315 132.2 (129.9, 134.5) 74.5 (73.3, 75.8) 57.7 (56.0, 59.3) 93.7 (92.3, 95.2)
Group 2 AG 1173 132.9 (131.5, 134.3) 75.1 (74.3, 75.8) 57.8 (56.9, 58.8) 94.3 (93.4, 95.2)
Group 3 GG 969 132.7 (131.2, 134.1) 75.1 (74.3, 75.9) 57.5 (56.5, 58.6) 94.3 (93.4, 95.3)
P for trend 0.91 0.44 0.66 0.62
Interaction ADH2 ALDH2 2450
Group 1 AAþAG AAþAG 1397 132.8 (131.5, 134.1) 75.1 (74.4, 75.8) 57.7 (56.8, 58.6) 94.4 (93.5, 95.2)
Group 2 AAþAG GG 891 132.7 (131.2, 134.2) 75.2 (74.4, 76.0) 57.5 (56.4, 58.5) 94.4 (93.4, 95.4)
Group 3 GG Any genotype 162 131.4 (128.3, 134.5) 73.3 (71.7, 75.0) 58.0 (55.9, 60.2) 92.7 (90.7, 94.7)
P for trend 0.42 0.21 0.85 0.27
Current drinkers
ADH2 (rs1229984) 2044
Group 1 AA 1035 133.2 (131.2, 135.1) 77.4 (76.4, 78.4) 55.8 (54.4, 57.1) 96.0 (94.8, 97.2)
Group 2 AG 850 133.2 (131.2, 135.1) 77.0 (76.1, 78.1) 56.1 (54.8, 57.5) 95.8 (94.5, 97.0)
Group 3 GG 159 136.7 (133.3, 140.1)*,# 78.0 (76.2, 79.8) 58.7 (56.4, 61.0)*,# 97.6 (95.4, 99.7)
P for trend 0.15 0.97 0.039 0.44
ALDH2 (rs671) 2044
Group 1 AA 85 130.7 (126.0, 135.3) 76.1 (73.6, 78.5) 54.6 (51.4, 57.8) 94.3 (91.3, 97.3)
Group 2 AG 717 133.2 (131.1, 135.3) 76.7 (75.6, 77.8) 56.6 (55.1, 58.0) 95.5 (94.2, 96.9)
Group 3 GG 1242 133.5 (131.7, 135.3) 77.5 (76.6, 78.5) 56.0 (54.7, 57.2) 96.2 (95.0, 97.4)
P for trend 0.35 0.06 0.91 0.13
Interaction ADH2 ALDH2 2036
Group 1 AAþAG AAþAG 730 132.6 (130.5, 134.7) 76.6 (75.4, 77.7) 56.0 (54.6, 57.5) 95.2 (93.9, 96.6)
Group 2 AAþAG GG 1147 133.4 (131.6, 135.3) 77.6 (76.6, 78.6)* 55.8 (54.6, 57.1) 96.2 (95.0, 97.4)
Group 3 GG Any genotype 159 136.6 (133.3, 140.0)* 77.9 (76.1, 79.7) 58.7 (56.4, 61.0)*,# 97.5 (95.3, 99.7)*
P for trend 0.035 0.035 0.15 0.025
Abbreviations: ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase, BP, blood pressure; CI, confidence interval; HDL, high-density lipoprotein; PP, pulse pressure; MAP, mean arterial
blood pressure.
Compared with group 1: *Po0.05. Compared with group 2: #Po0.05.
aAdjustment for age, education, occupation, smoking, physical activity, body mass index, as well as fasting total cholesterol, triglyceride, HDL cholesterol, glucose and frequency of drinking (for
current drinkers only).
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alcohol drinking behavior,5 the association between ALDH2 and
blood pressure became statistically nonsignificant after taking into
account the frequency or amount of alcohol consumption in our
study. As the ALDH2 genotype influences the blood acetaldehyde
level, whereas the ADH2 genotype influences the blood ethanol level
after alcohol drinking as in Figure 1, our results suggest that the
hypertensive effect of alcohol drinking is due to ethanol rather than
acetaldehyde. This finding is consistent with some but not all previous
studies. In an earlier study on 898 middle-aged male Japanese, no
association was found between blood pressure and ADH2 or ALDH2
genotypes after adjusting for age, body mass index and volume of
alcohol consumption.6 However, as the sample size was small, the null
association in this study should be interpreted with caution. Another
study of 335 Japanese showed that the relationship between alcohol
and blood pressure was significantly stronger in those with the GG
ADH2 genotype than those with the AA or AG genotype.16 Moreover,
the authors also indicated that those with the ADH2 GG genotype
were likely to develop hypertension because of excessive alcohol use.
However, in our study, we have also controlled for frequency or
amount of alcohol use in the model and found that older male
drinkers with the GG ADH2 genotype had a higher blood pressure
than alcohol drinkers with other genotypes. To remove the
confounding effect of ADH2 genotype, we analyzed the association
between ALDH2 genotypes and blood pressure in men with the AA/
AG ADH2 genotype and found no associations (table not shown),
which was in accordance with previous studies6,16 showing that
ADH2 genotype, but not ALDH2 genotype, modifies the association
of alcohol with blood pressure. However, in a study of excessive male
drinkers (4300 g of ethanol per week), the prevalence of the ADH2
AA genotype was significantly greater in those with higher SBP,22
suggesting that the ADH2 AA genotype but not GG genotype
weakens the relationship between alcohol and blood pressure.
However, participants in this study were hospital workers, included
only a few heavy drinkers and had a mean age of 46 years, and the
frequency or amount of alcohol use was not adjusted in the model.
A confounding effect from excessive alcohol use could not be
ruled out.
In the present study, we found that the ADH2 GG genotype was
associated with hypertension in alcohol drinkers after adjustment for
frequency of alcohol use. Hence, the relationship between ADH2 and
hypertension could not be fully explained by different levels of alcohol
consumption. Ethanol accumulation might be considered a key
pathway. The possible mechanisms by which ethanol increases blood
pressure include: (a) a direct effect on the central nervous system, by
interfering with central inhibitory pathways, which control the
vasomotor center or increasing sympathetic activity,25 (b) activation
of the rennin–angiotensin system by ethanol,26 (c) aortic endothelial
oxidative injury and downregulation of the nitric oxide generating
system,27 and (d) magnesium deficiency.28 However, the actual effect
of ethanol on blood pressure is unclear. Further experimental studies
are warranted to examine the mechanism underlying the relationship
between blood ethanol concentration and blood pressure, taking into
account different ADH2 genotypes.
Several limitations of this study should be noted. First of all, as
subjects in the present study were older Chinese people from
Southern China, most of them were light to moderate drinkers.
A 2001 World Health Organization sponsored survey of 24 992
Chinese residents across five areas of China showed an annual ethanol
consumption of 4.5 l (s.d.¼ 10.9) among adults aged 15 years and
older, which was low compared with Western countries: by compar-
ison, annual alcohol use was about 8.6 l per person in 2001 in
Europe.29 Moreover, people living in Southern China have lower
levels of alcohol use than those in the North.2 Given the limited
number of subjects in the present study who were heavy alcohol users,
whether the effect of heavy drinking on hypertension varies with
ADH2 genotype could not be assessed. Secondly, levels of alcohol use
among Chinese women were too low, so we could not examine the
associations among women. Thirdly, this is not a fully population-
representative study, and participants included were homogenous
Southern Chinese from one city. Earlier studies have shown different
distributions of ADH2 genotypes in different ethnic populations, such
as Chinese, Japanese, Brazilians and African Americans.8,30,31 Further
studies are needed to examine whether ADH2 genotypes modify the
effect of alcohol on blood pressure in other ethnic groups.
The strengths of the present study include a large sample size
(which enabled a detailed analysis of gene–environment interactions
by assessing the alcohol–blood pressure relationship in participants
who were or were not alcohol drinkers), the focus on a community-
based sample with light to moderate level of alcohol use, and the
adjustment of many potential confounding factors. Moreover, the
current study, for the first time systematically considered ethanol
metabolism in human body, including both acetaldehyde and acetic
acid, and clearly showed that current drinkers with an inactive ADH2
genotype had a significantly increased risk of hypertension.
The current study employed genetic polymorphism of an alcohol
metabolism enzyme as an instrumental variable to obtain an unbiased
Table 3 Adjusted ORs (95% confidence interval) of hypertension for ADH2 and ALDH2 polymorphisms in older Chinese men






(%) Model 1 n
Hypertension
(%) Model 1 Model 2a Model 3a
AAþAG AAþAG 1397 43.5 1.00 829 39.1 1.00 1.00 1.00
AAþAG GG 891 45.5 1.09 (0.91, 1.31) 1309 43.9 1.21 (1.01, 1.46)* 1.15 (0.95, 1.39) 1.15 (0.96, 1.40)






P-value 0.56 0.33 0.005 0.008 0.020 0.021
P for trend 0.75 0.98 0.001 0.002 0.008 0.008
Abbreviations: ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; OR, odds ratio; HDL, high-density lipoprotein.
Model 1: adjusting for age, education, occupation, smoking, physical activity, body mass index, as well as fasting total cholesterol, triglyceride, HDL cholesterol and glucose. Model 2: based on
model 1, additionally adjusting for frequency of drinking. Model 3: based on model 1, additionally adjusted for the amount of alcohol use (o or X140g per week).
*: Po0.05; **: Po0.01.
aCompared with (AA/AG ADH2þGG ALDH2), OR in GG ADH2¼1.40 (1.01, 1.96), P¼0.045 in model 2 and 1.40 (1.00, 1.94), P¼0.049 in model 3.
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estimation of the effect of alcohol on blood pressure, which was
unlikely to be confounded by other risk factors, such as smoking or
sodium intake, as in other observational studies. This study provided
the suggestive causal inference that the hypertensive effect of alcohol
drinking might be due to ethanol accumulation.
In conclusion, we found that the ADH2 genotype but not the
ALDH2 genotype was associated with blood pressure and hyperten-
sion in current drinkers. However, in never drinkers, no association
between ADH2 or ALDH2 genotypes and blood pressure was found,
indicating a gene–environment interaction effect on alcohol-induced
hypertension. Among current alcohol drinkers, individuals with a
GG ADH2 genotype had a higher risk of hypertension than those
with the AA or AG ADH2 genotype, suggesting a key role for ethanol
in alcohol-induced hypertension. Further studies in a larger sample,
including woman drinkers and younger drinkers, are warranted
to confirm our results.
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